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Gentamicin (Gm) is an aminoglycoside commonly used to treat bacterial infections
such as tularemia – the disease caused by Francisella tularensis. In addition to being
pathogenic, F. tularensis is found in environmental niches such as soil where this
bacterium likely encounters Gm producers (Micromonospora sp.). Here we show
that F. tularensis exhibits increased resistance to Gm at ambient temperature (26◦C)
compared to mammalian body temperature (37◦C). To evaluate whether F. tularensis
was less permeable to Gm at 26◦C, a fluorescent marker [Texas Red (Tr)] was
conjugated with Gm, yielding Tr-Gm. Bacteria incubated at 26◦C showed reduced
fluorescence compared to those at 37◦C when exposed to Tr-Gm suggesting that
uptake of Gm was reduced at 26◦C. Unconjugated Gm competitively inhibited uptake
of Tr-Gm, demonstrating that this fluorescent compound was taken up similarly to
unconjugated Gm. Lysates of F. tularensis bacteria incubated with Gm at 37◦C inhibited
the growth of Escherichia coli significantly more than lysates from bacteria incubated
at 26◦C, further indicating reduced uptake at this lower temperature. Other facultative
pathogens (Listeria monocytogenes and Klebsiella pneumoniae) exhibited increased
resistance to Gm at 26◦C suggesting that the results generated using F. tularensis may
be generalizable to diverse bacteria. Regulation of the uptake of antibiotics provides
a mechanism by which facultative pathogens survive alongside antibiotic-producing
microbes in nature.
Keywords: Francisella, gentamicin, antibiotic resistance, Listeria monocytogenes, Klebsiella, gentamicin uptake,
temperature
INTRODUCTION
Gentamicin (Gm) is an aminoglycoside antibiotic used to treat bacterial infections, including
tularemia, a disease caused by Francisella tularensis (Alford et al., 1972; Jackson and Lester, 1978;
Mason et al., 1980; Hassoun et al., 2006). This antibiotic binds to the bacterial 30S ribosomal
subunit, which interferes with nascent polypeptide elongation (Mingeot-Leclercq et al., 1999).
This binding impairs the machinery that prevents misreading of mRNA as well as premature
termination of translation (Mingeot-Leclercq et al., 1999). In addition to being used clinically, Gm
is also used in the “Gm protection assay” – a common laboratory test designed to quantify the
survival and growth of intracellular pathogens in host cells (Isberg and Falkow, 1985; Hilbi et al.,
2001; Horzempa et al., 2008b, 2011; Wisner et al., 2012; Schmitt et al., 2013).
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Due to the highly polar nature of aminoglycosides, these
antibiotics pass through the gram-negative outer membrane by
disrupting Mg2+ bridges that stabilize the lipopolysaccharide
molecules (Hancock, 1981; Mingeot-Leclercq et al., 1999).
Import of aminoglycosides such as Gm through the cytoplasmic
membrane is mediated through an energy-dependent process
powered by proton motive force (PMF; Hancock, 1981; Taber
et al., 1987). The speciﬁc cytoplasmic membrane transport
machinery for Gm uptake has not yet been elucidated. Bacterial
resistance to aminoglycosides can be facilitated by diminished
permeability (Davies, 1971), and therefore understanding
the molecular mechanism mediating Gm transport, and the
regulation of this process is important.
As the body of an animal that died from tularemia
decomposes, the F. tularensis bacteria are likely to inhabit the
soil that absorbs the decaying material. Although F. tularensis
has been identiﬁed in soil environments (Barns et al., 2005;
Berrada and Telford, 2010; Broman et al., 2011), little is known
about interactions with the microbiota, or how F. tularensis
survives the chemical and physical stresses associated with a
terrestrial inhabitance. For instance, the aminoglycoside Gm is
naturally produced by the soil bacterium, Micromonospora sp.
(Luedemann and Brodsky, 1963). Presumably, F. tularensis and
other pathogenic bacteria that transiently occupy a soil niche
would exhibit a means to survive this and other antibiotics
produced by competingmicroorganisms prior to the colonization
of a subsequent host.
Here we show that F. tularensis is more resistant to Gm
at 26◦C (a lower environmental temperature) than at 37◦C
(mammalian body temperature). This resistance is mediated
by diminished antibiotic uptake at the lower temperature.
Other pathogenic bacteria (Listeria monocytogenes and Klebsiella
pneumoniae) exhibited similar enhanced resistance at 26◦C,
suggesting that the temperature-dependent uptake of Gm is
generalizable to other microbes. We propose that bacteria that
experience both a pathogenic and a temporary terrestrial life
cycle evolved to utilize low temperature as a cue to decrease
aminoglycoside uptake, increasing survival during habitation
with competing bacteria that produce aminoglycosides and other
antibiotics. During infection, these pathogenic bacteria inhabit
an environment free of antibiotic-producing competing microbes
(until antibiotics were introduced for clinical use approximately
75 years ago).
MATERIALS AND METHODS
Bacterial Strains and Media
The strains of bacteria used in this study are listed in Table 1.
Francisella bacteria cultivated on chocolate II agar (BD) were
used to inoculate trypticase soy broth (TSB, BD) supplemented
with 0.1% cysteine HCl (TSBc). L. monocytogenes bacteria
cultivated on chocolate II agar were used to inoculate TSB
supplemented with 0.6% yeast extract. K. pneumoniae bacteria
were grown in TSB and Escherichia coli bacteria were cultured in
LB broth. Broth cultures were incubated at 37◦C with agitation.
Kanamycin (Km) was included in the media at 10 μg/ml when
TABLE 1 | Bacterial strains used in this study.
Bacterial Strain Reference
Francisella tularensis subsp. holarctica live vaccine strain Karen Elkins
F. tularensis subsp. tularensis Schu S4 (NR-643) NIH BEI Resources
Repositorya
F. tularensis LVS emrA1transposon mutant KmR Ma et al., 2014
F. tularensis LVS pyrF Horzempa et al., 2010
Escherichia coli DH5α Invitrogen
F. novicida U112 Karen Elkins
Listeria monocytogenes EGD Douglas Drevets
Klebsiella pneumoniae WLU-MCCb
aNational Institutes of Health Biodefense and Emerging Infections (NIH BEI)
Research Resources Repository, National Institute of Allergy and Infectious
Diseases.
bWLU-MCC, West Liberty University Microbiology Culture Collection, bacterial
species routinely verified by standard metabolic and physiological tests.
necessary. All work with F. tularensis Schu S4 was conducted at
the University of Pittsburgh in a biosafety level 3 facility with
approval from the Centers for Disease Control and Prevention
Select Agent Program.
Time-Kill Assays
Stationary phase broth cultures were suspended in phosphate
buﬀered saline (PBS) or TSBc as indicated to a concentration
of 2 × 108 CFU/ml (F. tularensis) or 2 × 106 CFU/ml
(L. monocytogenes or K. pneumoniae). This phase was selected
to minimize the eﬀect of temperature on growth rate and
metabolism of the bacteria (Horzempa et al., 2008a). Bacteria
were normalized using OD600 and treated with 0, 50, 100,
or 500 μg/ml Gm sulfate and incubated at 26 or 37◦C.
Antibiotic concentrations capable of showing signiﬁcant bacterial
killing over 2 h were selected. PABN (25 μM Phenylalanine-
Arginine Beta-Naphthylamide) or CCCP (25 μM cyanide-m-
chlorophenylhydrazone) was added when indicated. At the times
indicated, suspensions of bacteria were serially diluted in PBS
and plated to determine CFU.
Antibiotic Disk Diffusion Assays
Stationary phase broth cultures were diluted to an optical density
(A600) of 0.3. 100 μl of this suspension was spread plated onto
solid medium (chocolate II agar for F. tularensis, LB agar for
E. coli, trypticase soy agar for K. pneumoniae). Sterile Whatman
ﬁlter disks infused with antibiotics were placed onto the surface of
these plates that were subsequently incubated at 37◦C overnight.
The diameters of the zones of inhibition were measured using a
metric ruler.
A variation of this disk diﬀusion assay was used to determine
whether F. tularensis exhibited diminished uptake of Gm at 26◦C.
Here, F. tularensis LVS broth cultures were grown to stationary
phase. Cultures were diluted to an optical density (A600) of
0.3 in TSBc and were incubated with 500 μg/ml Gm at 26 or
37◦C. After 15 min, these bacteria were washed twice with PBS
(each wash consisted of centrifuging the bacterial suspension at
16,300× g for 3 min, and suspending the pellet in PBS). After the
second wash, bacteria were centrifuged similarly and the pellet
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was suspended in 25 μl deionized water. This suspension was
sonicated (3 s burst) to lyse cells. Lysates were added to a ﬁlter
disk that was placed onto solid medium that had been spread
plated with E. coli. These plates were incubated at 37◦C overnight
and subsequently, zones of inhibition were measured using a
metric ruler.
Uptake of Gm Conjugated to Texas Red
Texas Red R©-X, succinimidyl ester (Life Technologies) was
conjugated to Gm as previously described (Sandoval et al.,
1998; Li et al., 2011). Brieﬂy, a 300:1 molar ratio (Gm sulfate:
Texas Red succinimidyl ester) were incubated together in K2CO3
(100 mM, pH = 10; Li et al., 2011). These conditions minimize
the addition of multiple ﬂuorescent moieties to a single Gm
molecule and also ensure a minimal amount of free, unbound
Texas Red (Sandoval et al., 1998; Li et al., 2011). Unbound
Texas Red was removed using PierceTM Dye Removal Columns
(Thermo Scientiﬁc) according to protocol of the manufacturer.
Conjugation and removal of unbound Texas Red were veriﬁed by
agarose gel electrophoresis (data not shown).
Francisella tularensis LVS bacteria were suspended in TSBc
and treated with Tr-Gm (at an amount equivalent to 128 μg/ml
Gm) at either 26 or 37◦C. To measure bacterial ﬂuorescence
at the times indicated, F. tularensis cells were centrifuged at
16,300× g for 3 min, the pellets were washed twice with PBS, and
after an additional centrifugation were suspended in PBS. The
ﬂuorescence was determined using an Eppendorf plate reader
using a 535/595 ﬁlter.
When indicated, bacteria were incubated with both Tr-Gm
(at an amount equivalent to 128 μg/ml Gm) and increasing
concentrations of Gm (0, 50, 100, 150, or 200 μg/ml) for 15 min
at 37◦C. Bacteria were centrifuged, washed twice in PBS, and then
ﬂuorescence was determined using an Eppendorf plate reader
with a 535/595 ﬁlter.
Statistical Analyses
Data were analyzed for signiﬁcant diﬀerences using GraphPad
Prism software. The statistical tests used are indicated in the
ﬁgure legends.
RESULTS
The Gm protection assay is used to quantify uptake and
intracellular replication of pathogenic bacteria (Isberg and
Falkow, 1985; Horzempa et al., 2011). This method involves the
utilization of Gm, an aminoglycoside that permeates poorly into
eukaryotic cells, to kill extracellular bacteria. Cultured host cells
that had been incubated with pathogenic bacteria for a period
of time are treated with Gm, washed, lysed, and intracellular
CFU are determined by plating serial dilutions. When working
out the conditions for this assay using F. tularensis, we observed
that the incubation temperature substantially aﬀected the ability
of Gm to reduce bacterial viability (Figure 1). Here, bacteria
were incubated with Gm suspended in PBS and incubated
at 37◦C (mammalian body temperature) or at 26◦C (ambient
temperature). Incubation of F. tularensis Schu S4 with Gm
(100 μg/ml in PBS) at 37◦C for 1 h resulted in a 10,000-fold
reduction of CFU, whereas incubation with this same antibiotic
at 26◦C only reduced CFU by 10-fold (Figure 1A). This indicated
that the F. tularensis Schu S4 bacteria were more resistant to
Gm at ambient versus mammalian body temperature. Incubation
of F. tularensis Schu S4 with 20 μg/ml Gm for 1 h at either
temperature did not result in a signiﬁcant reduction of viability
(data not shown). In addition, the attenuated F. tularensis
LVS strain exhibited a similar phenotype with increased Gm
resistance at 26◦C (Figure 1B). Notably, fewer F. tularensis
LVS bacteria were killed by the 100 μg/ml Gm than Schu S4,
indicating an intrinsic disparity in Gm susceptibility between
these strains, which is consistent with other published reports
(Kreizinger et al., 2013). However, at both 100 and 500 μg/ml
Gm, F. tularensis LVS bacteria appeared to be more resistant
at the lower temperature (26◦C) than at mammalian body
temperature (Figure 1B).
Because the attenuated F. tularensis LVS also exhibited
temperature-dependent Gm resistance, we utilized this strain
to investigate the mechanism of this resistance throughout
this study. Resistance to aminoglycosides can be manifested
through drug inactivation, ribosomal alteration, antibiotic eﬄux,
metabolic dormancy, or by diminished uptake (Mingeot-Leclercq
et al., 1999; Allison et al., 2011). The genome of F. tularensis
does not encode any proteins homologous to those known
to inactivate aminoglycosides (data not shown). Moreover
mutations that lead to modiﬁcation of the ribosome structure
are unlikely to cause this resistance at 26◦C given the short
duration of this assay and magnitude of surviving bacteria at
26◦C compared to 37◦C. Therefore, we ﬁrst experimentally
tested whether multi-drug eﬄux was enhanced at 26◦C.
EmrA1 comprises a component of a multidrug eﬄux pump of
F. tularensis (Ma et al., 2014). This membrane fusion protein
actively expels toxic materials, such as various types of antibiotics,
from the bacterial cytosol (Ma et al., 2014). Similar to wild-
type bacteria, the F. tularensis emrA1 mutant was more resistant
to Gm at 26◦C compared to 37◦C (Figure 2). This suggests
that enhanced EmrA1-mediated eﬄux is not responsible for the
increased resistance to Gm at 26◦C.
To further investigate whether enhanced Gm eﬄux mediated
the increased resistance at 26◦C, bacteria were treated with
PABN, a non-speciﬁc inhibitor against RND-type multidrug
eﬄux pumps (Renau et al., 1999; Lamers et al., 2013; Opperman
and Nguyen, 2015). Together with the PABN, these bacteria were
treated with Gm, incubated at 26 or 37◦C, and were then plated
to determine viable CFU (Figure 3A). Inclusion of PABN did
not reduce resistance at 26◦C, providing further evidence that
enhanced eﬄux at this lower temperature does not mediate the
observed resistance. F. tularensis LVS has been shown to utilize
multidrug eﬄux to expel nalidixic acid (NA) and tetracycline (Tc)
(Forslund et al., 2006; Gil et al., 2006; Bina et al., 2008; Platz et al.,
2010). Antibiotic disk diﬀusion assays indicated the inclusion of
PABN increased the susceptibility of F. tularensis LVS to both
NA (Figure 3B) and Tc (Figure 3C) – ﬁndings consistent with
the inhibition of eﬄux machinery. These data verify that PABN
was likely inhibiting antibiotic eﬄux machinery during the assay
depicted in Figure 3A. Altogether, Figures 2 and 3 indicate that
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FIGURE 1 | Temperature-dependent Gm resistance of Francisella tularensis. F. tularensis Schu S4 (A) and LVS (B) showed increased resistance to
gentamicin (Gm) at ambient temperature (26◦C) compared to mammalian body temperature (37◦C). Bacteria were cultivated in general growth media, suspended in
PBS, and treated with Gm at the indicated temperature. Bacteria were diluted and plated for viable CFU at the indicated times. Plotted values represent mean
CFU ± SD. Log-transformed data were analyzed using a two-way ANOVA and a Sidak’s multiple comparisons test. ∗P < 0.05 Schu S4 1 h 26◦C vs. 37◦C (A); LVS
1 h 26◦C vs. 37◦C Gm (500 μg/ml), 2 h 26◦C vs. 37◦C Gm (100 and 500 μg/ml; B).
the increased resistance toGm at 26◦Cby F. tularensis is not likely
mediated by enhanced eﬄux.
The observed increased resistance to Gm at 26◦C was
manifested in bacteria that were suspended in PBS resulting
in starvation conditions. Because lack of nutrients can trigger
tolerance to antibiotics (Nguyen et al., 2011), we hypothesized
that the lower temperature enhanced the starvation response,
increasing the number of bacteria surviving at 26◦C. To test
whether starvation conditions augmented resistance at 26◦C, we
incubated bacteria treated with Gm in TSBc – a rich medium
routinely used for the cultivation of F. tularensis. Similarly
to when bacteria were incubated in PBS, suspension in TSBc
resulted in an increased resistance to Gm at 26◦C compared
to 37◦C (Figure 4). This suggests that an enhanced starvation
response at 26◦C did not increase resistance to Gm.
To further assess whether a reduced metabolic state mediated
the observed resistance at ambient temperature, we treated the
F. tularensis LVS pyrF mutant with Gm, incubated at 26 or
37◦C, and determined the number of viable CFU (Figure 5). This
strain is incapable of synthesizing uracil, and therefore grows
at a reduced rate (Horzempa et al., 2010) which is indicative
of a diminished metabolism. At 26◦C, the F. tularensis LVS
pyrF bacteria were similarly resistant to Gm as wild type
bacteria (Figure 5) indicating that a reduced metabolism was
not responsible for the resistance to Gm at 26◦C. Notably, the
F. tularensis LVS pyrF mutant bacteria were more sensitive
to Gm than wild type bacteria at 37◦C, indicating that a
diminished metabolic capability seemingly increases sensitivity
to this antibiotic under the conditions tested. Altogether, the
results from Figures 4 and 5 indicate that an enhanced
starvation response at 26◦C is not likely responsible for increasing
F. tularensis resistance to Gm.
We next sought to test whether decreasing uptake of Gm at
26◦C mediated the observed resistance. Gram-negative bacteria
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FIGURE 2 | Mutation of emrA1 gene in LVS does not change this bacterium’s resistance to Gm at 26◦C. EmrA1 is a member of the membrane fusion
protein family and is associated with the outer membrane TolC homolog SilC, to form a multidrug efflux pump. Increased Gm-resistance at 26◦C is not mediated via
efflux through the encoded efflux pump. Bacteria were suspended in PBS, and treated with Gm (100 μg/ml) for 2 h at the indicated temperature. Bacteria were
diluted and plated for viable CFU at the times indicated. Plotted values represent mean CFU ± SD. Log-transformed data were analyzed using a two-way ANOVA
and a Sidak’s multiple comparisons test. ∗P < 0.05 LVS 2 h 26 vs. 37◦C Gm (100 μg/ml), emrA1 2 h 26◦C vs. 37◦C Gm (100 μg/ml). LVS vs. emrA1 not significant.
FIGURE 3 | Inhibition of multidrug efflux does not reduce the resistance of F. tularensis LVS to Gm at 26◦C. Bacteria were cultivated in general growth
media, suspended in PBS, and treated with Gm, or Gm + PABN (25 μM Phenylalanine-Arginine Beta-Naphthylamide; efflux pump inhibitor) at the indicated
temperature (A). Bacteria were diluted and plated for viable CFU at the indicated times. Plotted values represent mean CFU ± SD. F. tularensis LVS bacteria were
subjected to disk diffusion assays in the presence or absence of PABN to show that this compound was capable of inhibiting multi-drug efflux (B,C) as reported for
other bacteria F. tularensis LVS is known to utilize multidrug efflux to expel nalidixic acid (NA) and tetracycline (Tc). Disks contained 30 μg of the indicated antibiotic.
Bars represent the mean of the zones of inhibition ±SE. Media containing PABN significantly increased the zones of inhibition produced by NA (B; ∗P < 0.0001,
unpaired t-test) and Tc (C; ∗P = 0.0271, unpaired t-test) likely due to reduced efflux activity.
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FIGURE 4 | Incubation in a rich medium maintains the observed Gm resistance at 26◦C. Bacteria were cultivated in general growth media, suspended in
trypticase soy broth supplemented with 0.1% cysteine (TSBc), and treated with Gm at the indicated temperature. Bacteria were diluted and plated for viable CFU at
the indicated times. Plotted values represent mean CFU ± SD. Log-transformed data were analyzed using a two-way ANOVA and a Sidak’s multiple comparisons
test. ∗P < 0.05 LVS 26◦C vs. 37◦C Gm (100 μg/ml) at 1 and 2 h.
FIGURE 5 | Francisella tularensispyrF is not more resistant to Gm than wild type LVS. Bacteria were cultivated in general growth media, suspended in
TSBc, and treated with Gm at the indicated temperature. Bacteria were diluted and plated for viable CFU at the indicated times. Plotted values represent mean
CFU ± SD. Log-transformed data were analyzed using a two-way ANOVA and a Sidak’s multiple comparisons test. LVS 26◦C vs. pyrF Gm (100 μg/ml) not
significant. ∗P < 0.05 LVS 26◦C vs. 37◦C Gm (100 μg/ml) at 1 and 2 h; ∗P < 0.05 LVS 37◦C vs. pyrF Gm (100 μg/ml) at 1 and 2 h.
import Gm utilizing PMF (Taber et al., 1987). Utilization of
protonophores inhibit PMF, and thusly reduce bacterial uptake
of aminoglycosides (Taber et al., 1987). To determine whether
F. tularensis takes up Gm similarly to other Gram-negative
bacteria, the protonophore, CCCP was used. Here, bacteria were
treated with CCCP in combination with Gm, incubated at 26 or
37◦C, and viable CFU were determined at the times indicated
(Figure 6). The bacteria treated with CCCP survived Gm
treatment, regardless of the incubation temperature, suggesting
that this protonophore likely prevented uptake of Gm. This
indicated that PMF mediates the uptake of Gm in F. tularensis
similarly to other bacteria.
To determine whether F. tularensis took up less Gm at
26◦C, we ﬂuorescently labeled Gm with Texas Red (Tr-Gm) and
subsequently analyzed cellular ﬂuorescence similarly to previous
investigations (Sandoval et al., 1998; Steyger et al., 2003; Allison
et al., 2011). F. tularensis LVS bacteria were treated with Tr-
Gm, incubated at 26 or 37◦C, and at the indicated times, were
washed three times with PBS, and analyzed for red ﬂuorescence
using a plate reader (Figure 7A). At each time point, bacteria
incubated at 37◦C were more ﬂuorescent than those incubated at
26◦C (Figure 7A). This suggested that at the lower temperature,
bacteria took up less Tr-Gm. Inclusion of unconjugated Gm
competitively inhibited uptake of Tr-Gm (Figure 7B). This
indicated that the ﬂuorescently labeled form of this antibiotic was
taken up similarly to the unmodiﬁed Gm. These data indicate that
the increased resistance of F. tularensis to Gm at 26◦C (Figures 1
and 4) was likely due to diminished uptake of this antibiotic.
To conﬁrm that F. tularensis took up less Gm at 26◦C
compared to 37◦C, F. tularensis LVS bacteria were incubated with
Gm at 26 or 37◦C, and after a short period of time (15 min),
these cells were washed twice with PBS, suspended in deionized
water, and then lysed. Lysates were added to ﬁlter disks that
were placed onto LB agar plates that had been lawn-streaked
with E. coli. After incubation, zones of inhibition were measured.
Disks infused with lysates of LVS bacteria that had been treated
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FIGURE 6 | Francisella tularensis LVS takes up Gm using proton motive force (PMF) similarly to other Gram-negative bacteria. Bacteria were cultivated
in general growth media, suspended in TSBc, and treated with Gm, or Gm + CCCP (25 μM cyanide-m-chlorophenylhydrazone; a PMF inhibitor) at the indicated
temperature. Bacteria were diluted and plated for viable CFU at the indicated times. Plotted values represent mean CFU ± SD. Log-transformed data were analyzed
using a two-way ANOVA and a Sidak’s multiple comparisons test. ∗P < 0.05 LVS 26◦C vs. 37◦C Gm (100 μg/ml) at 1 and 2 h. LVS 26◦C vs. 37◦C CCCP + Gm
(100 μg/ml) not significant.
FIGURE 7 | Francisella tularensis LVS takes up less Gm conjugated to Texas Red (Tr-Gm) at 26◦C. F. tularensis LVS showed an increase in Tr-Gm
fluorescence at mammalian body temperature (37◦C) compared to ambient temperature (26◦ ) (A). Bacteria were suspended in TSBc and treated with Tr-Gm (at an
amount equivalent to 128 μg/ml Gm) at the indicated temperature. Bacteria were centrifuged, the pellets were washed twice and then suspended in PBS at the
indicated times. The fluorescence was determined using an Eppendorf plate reader with a 535/595 filter. Plotted values represent mean relative fluorescence units
±SE. Data were analyzed using a two-way ANOVA and a Sidak’s multiple comparisons test. ∗P < 0.05 37◦C vs. 26◦C at 2 h; 37◦C at 2 h vs. 37◦C 15 min or 1 h.
26◦C 2 h vs. 26◦C 15 min or 26◦C 1 h, not significant. To show that Tr-Gm was taken up through the Gm transporter (B), bacteria were incubated with Tr-Gm and
increasing concentrations of Gm for 15 min at 37◦C. Bacteria were centrifuged, washed in PBS, and then fluorescence was determined using an Eppendorf plate
reader with a 535/595 filter. Plotted values represent mean relative fluorescence units ±SE. Data were analyzed using a one-way ANOVA and a Dunnetts’s multiple
comparisons test. ∗P = 0.0150, 0 μg/ml vs. all other conditions.
with Gm and incubated at 37◦C were signiﬁcantly larger than
those produced by lysates of antibiotic-treated bacteria incubated
at 26◦C (Figure 8). Notably, lysates from bacteria not treated with
antibiotic did not produce zones of inhibition (data not shown).
This experiment conﬁrms that the increased resistance to Gm at
26◦C is due to diminished uptake by F. tularensis LVS.
Determining whether other bacteria possess increased Gm
resistance at lower ambient temperature could provide further
insight into the mechanism and the prevalence of this
phenomenon. We therefore tested the impact of temperature
on the Gm resistance of F. novicida, a bacterium related to
F. tularensis that has been isolated from saltwater and rarely from
human infections (Whitehouse et al., 2012; Kingry and Petersen,
2014). F. novicida bacteria were exposed to Gm followed by
incubation at 26 or 37◦C. Unlike F. tularensis, F. novicida
showed a slight, but signiﬁcantly increased resistance to Gm
at 37◦C 1 h after exposure (Figure 9A). However, after 2 h,
bacteria incubated at either temperature were equally susceptible
(Figure 9A). These data suggest that although genetically similar,
F. tularensis and F. novicida regulate the uptake of Gmdiﬀerently.
We subsequently tested whether diverse bacteria exhibited
increased Gm resistance at lower ambient temperatures similar
to F. tularensis. L. monocytogenes is an intracellular pathogen
that has been isolated from environmental sources. However, this
bacterium is gram-positive (Firmicutes) indicating a great deal of
taxonomic separation from F. tularensis. Similarly to F. tularensis,
K. pneumoniae is a gram-negative γ-proteobacterium. However,
K. pneumoniae is an opportunistic pathogen that is not associated
with an intracellular lifestyle. Both L. monocytogenes (Figure 9B)
and K. pneumoniae (Figure 9C) exhibited increased resistance to
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FIGURE 8 | Growth of Escherichia coli is inhibited more by F. tularensis
LVS lysates from bacteria incubated with Gm at 37◦C. F. tularensis were
suspended in TSBc and incubated with 500 μg/ml Gm at 26◦C or 37◦C.
Subsequently, these bacteria were washed twice with PBS, then suspended
in deionized water and sonicated for 3 s to lyse. Lysates were added to a filter
disk that was placed onto a lawn-streaked agar plate of E. coli. These plates
were incubated at 37◦C overnight. E. coli grew up to the filter disk on plates
containing F. tularensis LVS lysates from bacteria that were incubated in TSBc
at 26◦C and 37◦C without Gm (not shown). Bars represent the mean of the
zones of inhibition ±SE. p = 0.0114, unpaired t-test.
Gm at 26◦C suggesting that diverse bacteria have developed a
temperature-dependent resistance to this antibiotic. To conﬁrm
these ﬁndings, we conducted antibiotic disk diﬀusion assays in
which plates that had been lawn-streaked with bacteria were
incubated at 37 or 26◦C. Incubation at the lower temperature
yielded inconsistent and sparse growth of F. tularensis LVS,
therefore negating the possibility of using this conﬁrmatory test
(data not shown). However, antibiotic disk diﬀusion assays for
F. novicida, L. monocytogenes, and K. pneumoniae mirrored the
time kill assays at 1 h post-exposure to Gm (Figures 9D–F).
In other words, F. novicida was more resistant to Gm at 37◦C,
while L. monocytogenes and K. pneumonaie bacteria were more
resistant at 26◦C.
DISCUSSION
Data presented here indicated that F. tularensis and other bacteria
that exist as facultative pathogens exhibit increased resistance
to Gm at a lower temperature associated with environmental
niches, versus mammalian body temperature. Evidence indicated
that this increased resistance was due to diminished permeability
to Gm at the lower temperature. This work describes a
mechanism in which an important pathogen interacts with its
non-host environment. F. tularensis has been identiﬁed in various
environmental niches, including the soil (Barns et al., 2005;
Berrada and Telford, 2010; Broman et al., 2011) – an environment
that also harbors antibiotic producers. One such microbe,
Micromonospora, produces Gm (Luedemann and Brodsky, 1963;
Jao and Jackson, 1964). We propose here that F. tularensis and
other pathogenic microbes have evolved general mechanisms to
resist antibiotics during their existence outside of hosts. And,
as demonstrated by using K. pneumoniae and L. monocytogenes,
these bacteria use temperature as a cue to decrease permeability
to antibiotics such as aminoglycosides. Previously published data
indicated that transcription of a F. tularensis β-lactamase gene is
induced at 26◦C vs. 37◦C (Horzempa et al., 2008a).We have since
conﬁrmed that F. tularensis β-lactamase activity is more robust
at 26◦C (data not shown) indicating that lower environmental
temperature induces general resistance against many types of
antibiotics. Largely throughout the course of evolution (prior to
the clinical use of antibiotics in the 1940s), these mechanisms
were not necessary during mammalian infection as niches
occupied here are devoid of antibiotic-producing microbes.
The concentration of Gm used in many of the studies
represented in this manuscript are relatively high compared
to clinical use and soil concentrations which reach ∼mg/kg
quantities (Kümmerer, 2008). However, Micromonospora sp.
bacteria are capable of producing concentrations of Gm over
7 g/l in culture (Meenavilli et al., 2008) indicating that in
soil microenvironments adjacent to these antibiotic-producing
microbes, quantities could reach or even exceed levels similar to
those used in the studies outlined here.
This study models interactions that F. tularensis would have
with its environment during and following the decomposition
of an animal that perished as a result of tularemia. In this
soil environment (Barns et al., 2005; Berrada and Telford,
2010; Broman et al., 2011), F. tularensis is at some point
likely to encounter antibiotic-producing microbes. As this study
presented evidence that F. tularensis bacteria take up less
aminoglycosides at lower temperatures, future investigations
should focus on whether lower temperatures cue this bacterium
to restrict uptake of other antibiotics associated with soil
inhabitation, such as Tc. Little is known of the duration
F. tularensis exists outside of a host cell or organism, or whether
F. tularensis grows free from a host. Certainly, F. tularensis is
capable of being cultivated in the laboratory in culture media
devoid of host cells. However, due to the fastidious nature of
this organism, it is unlikely capable of replication in the absence
of essential host factors. Therefore, the increased resistance to
Gm at lower environmental temperatures demonstrated here
may provide an advantage until F. tularensis is phagocytosed or
engulfed by a protozoan or arthropod host (Abd et al., 2003;
Mahajan et al., 2011; Ozanic et al., 2015) – a niche inhabited with
a lower abundance of antibiotic-producing microbes.
Diminished uptake of Gm at 26◦C correlated with the
increased resistance of F. tularensis LVS at this lower temperature,
associating these two phenomena. Because a genetically similar
bacterium, F. novicida did not exhibit the same pattern
of resistance, increased membrane ﬂuidity at the higher
temperature was not likely responsible for the disparity in Gm
uptake. An alternative explanation would be diﬀerential activity
of a Gm transporter. Identiﬁcation of the protein responsible for
aminoglycoside uptake in bacteria has been elusive. Perhaps this
is because many diﬀerent proteins are capable of non-speciﬁcally
importing this category of antibiotics. A current focus of our
laboratory is to identify F. tularensis proteins responsible for the
import of Gm.
Lipopolysaccharide (LPS) structure substantially aﬀects the
permeability of bacteria to polar molecules (Nikaido, 2003).
Temperature greatly inﬂuences the structure of the lipid Amoiety
of the Francisella LPS molecule (Shaﬀer et al., 2007; Li et al.,
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FIGURE 9 | Francisella novicida, Listeria monocytogenes and Klebsiella pneumoniae exhibit temperature-dependent Gm resistance. F. novicida (A),
L. monocytogenes (B), or K. pneumoniae (C) bacteria were cultivated in general growth media overnight, suspended in PBS, and treated with Gm at the indicated
temperature. Bacteria were diluted and plated for viable CFU at the indicated times. Plotted values represent mean CFU ± SD. Log-transformed data were analyzed
using a two-way ANOVA and a Sidak’s multiple comparisons test. ∗P < 0.05 F. novicida 26◦C vs. 37◦C Gm (100 μg/ml) at 1 h (A); L. monocytogenes 1 h 26◦C vs.
37◦C Gm (100 and 500 μg/ml), 2 h 26◦C vs. 37◦C Gm (100 and 500 μg/ml); K. pneumoniae 26◦C vs. 37◦C Gm (50 μg/ml) at 1 and 2 h. Antibiotic disk diffusion
assays were carried out in which F. novicida (D), L. monocytogenes (E), or K. pneumoniae (F) bacteria were lawn streaked onto solid media, and incubated with filter
disks containing the indicated amount of Gm. These plates were incubated at the temperature indicated, and zones of inhibition were measured. Bars represent the
mean of the zones of inhibition ±SD. Disk diffusion data were analyzed using an unpaired t-test. ∗P = 0.0009 (D); ∗P = 0.0026 (E); ∗P = 0.0050 (F).
2012). Therefore, it is possible that the addition of the 3-OH
C16 acyl group at the lower environmental temperature could be
responsible for the decreased permeability to Gm. Investigations
to test this possibility are ongoing. However, L. monocytogenes
(a gram-positive bacterium) also exhibited increased resistance
to Gm at 26◦C. This indicates that LPS modiﬁcation in
response to temperature cues could not be the mechanism
utilized under all circumstances. Further testing will focus
on determining the extent of resistance mechanisms utilized
to resist aminoglycosides in response to lower environmental
temperatures.
Although data presented here indicated that the temperature-
dependent Gm resistance of F. tularensis is mediated by uptake
modulation, we cannot completely rule out the possibility that
this resistance is, at least in part, due to enhanced eﬄux
of aminoglycosides. In Pseudomonas aeruginosa, the MexXY
multidrug eﬄux system is one of the primary determinants
of aminoglycoside resistance (Morita et al., 2012). Although
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PABN is a non-speciﬁc inhibitor of RND-type eﬄux
pumps, this compound antagonized the activity of
aminoglycosides in a MexXY-dependent manner in
P. aeruginosa (Mao et al., 2001). If F. tularensis
possesses a homolog of the MexXY multidrug eﬄux
system or a functional equivalent, this machinery may
contribute to the temperature-dependent resistance observed
here.
An unanswered question raised by the data presented
here is: why have F. tularensis LVS and other pathogenic
bacteria evolved to import more Gm at mammalian body
temperature? We speculate that this is a consequence of
an overall upregulation of uptake machinery that occurs
in response to host temperature (Horzempa et al., 2008a).
We hypothesize that the Gm enters the cell non-speciﬁcally
through nutrient uptake transporters during this general
upregulation. This hypothesis is currently being tested in our
laboratory.
This work presented a novel observation – that F. tularensis
and other facultative pathogenic bacteria are more resistant
to Gm at lower ambient temperatures (26◦C) compared to
mammalian body temperature (37◦C). We show that this
resistance was mediated by diminished antibiotic uptake
at the lower temperature. We hypothesize that bacteria
experiencing both a pathogenic and a temporary terrestrial
life cycle may have evolved to utilize low temperature as a
cue to decrease aminoglycoside uptake, increasing survival
during habitation with competing bacteria that produce
aminoglycosides.
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